The comparable reduction in liver tumor burden observed in HBV+DEN-treated Il33KO and ST2KO mice demonstrated that IL-33’s cytokine function, rather than its nuclear function42, was responsible for HBV+DEN-mediated liver cancer development. This evidence concerns the gene IL33 and liver cancer.